NCT03048279Active, not recruiting
Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2
Source: ClinicalTrials.gov · Last updated 16 Apr 2026
Brief summary (registry, in English)
Objectives: To contribute new and prospective data to our existing database library for patients with MEN1 and MEN2 at The University of Texas M.D. Anderson Cancer Center.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 7 Feb 2017
- Start date
- 5 Sept 2001
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- M.D. Anderson Cancer Center
- NCT number
- NCT03048279
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 5 Sept 2001 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Individuals who are either non-MDACC registered patients or do not have a close relative who is an MEN patient registered at MDACC.
Who the study is looking for
- Registered MDACC patients diagnosed with MEN1 or MEN2.
- Close relatives of registered MDACC MEN patients.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas - MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.